Gritstone bio Inc. (NASDAQ: GRTS) Stock Information | RedChip

Gritstone bio Inc. (NASDAQ: GRTS)


$0.71
+0.0559 ( +8.50% ) 1.9M

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Market Data


Open


$0.71

Previous close


$0.66

Volume


1.9M

Market cap


$77.45M

Day range


$0.63 - $0.73

52 week range


$0.52 - $3.33

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Feb 05, 2024
4 Insider transactions 1 Feb 05, 2024
4 Insider transactions 1 Feb 05, 2024
4 Insider transactions 1 Feb 05, 2024
8-k 8K-related 13 Nov 08, 2023
10-q Quarterly Reports 79 Nov 08, 2023
8-k 8K-related 14 Sep 27, 2023
8-k 8K-related 12 Aug 15, 2023
10-q Quarterly Reports 76 Aug 09, 2023
8-k 8K-related 13 Aug 09, 2023

Latest News